Muscular Dystrophy Clinical Trials in Milan
7 recruitingMilan, Italy
Showing 1–7 of 7 trials
Recruiting
Phase 1Phase 2
A Phase 1/2 Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BMN 351 in Participants With Duchenne Muscular Dystrophy
Duchenne Muscular Dystrophy
BioMarin Pharmaceutical18 enrolled8 locationsNCT06280209
Recruiting
Phase 1Phase 2
A Study in Participants With Duchenne Muscular Dystrophy Amenable to Exon 44 Skipping to Evaluate the Safety and Efficacy of ENTR-601-44
Duchenne Muscular Dystrophy (DMD)
Entrada Therapeutics, Inc.24 enrolled14 locationsNCT07037862
Recruiting
Phase 1Phase 2
A Study in Participants With Duchenne Muscular Dystrophy Amenable to Exon 45 Skipping to Evaluate the Safety and Efficacy of ENTR-601-45
Duchenne Muscular Dystrophy (DMD)
Entrada Therapeutics, Inc.24 enrolled15 locationsNCT07038824
Recruiting
Phase 2Phase 3
Givinostat in Duchenne's Muscular Dystrophy Long-term Safety and Tolerability Study
Duchenne Muscular Dystrophy
Italfarmaco206 enrolled39 locationsNCT03373968
Recruiting
Characterization of the Natural History of LAMA2-RD and Identification of Novel Disease Biomarkers
LAMA2-MD (Merosin Deficient Congenital Muscular Dystrophy, MDC1A)
Università Vita-Salute San Raffaele45 enrolled1 locationNCT07125040
Recruiting
Phase 2
Pharmacokinetics and Safety of Givinostat in DMD Patients Ages From at Least 2 Years to Less Then 6 Years Old
Duchenne Muscular Dystrophy
Italfarmaco18 enrolled9 locationsNCT06769633
Recruiting
Phase 3
Efficacy, Safety and Tolerability of Givinostat in Non-ambulant Patients With Duchenne Muscular Dystrophy
Duchenne Muscular Dystrophy
Italfarmaco138 enrolled20 locationsNCT05933057